Thymalfasin and Recombinant Human IL-2 Injections in Treating Lymphocytopenia for Patients With Malignant Hematological Tumors
Clinical trial NCT06584006 · RECRUITING
Trial details
- NCT number
- NCT06584006
- Sponsor
- The First Affiliated Hospital of Xiamen University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-01
- Primary completion
- 2027-11-30
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.